No Data
No Data
Express News | TFF Pharmaceuticals Engages Outcome Capital as a Strategic Advisor for Evaluating Partnership and Licensing Opportunities
TFF Pharmaceuticals Announced A Regulatory Update On Its TFF TAC Clinical Program Following Its Recent Interaction With The FDA, Company To Provide More Detailed Regulatory Update In 3Q 2024
Express News | TFF Pharmaceuticals: Based on FDA Feedback, Does Not Expect Change to Timelines or Estimated Costs Associated With Clinical Advancement of TFF Tac
Express News | TFF Pharmaceuticals Provides Regulatory Update on Tacrolimus Inhalation Powder (TFF Tac) Clinical Program for the Prevention of Lung Transplant Rejection
Express News | TFF Pharmaceuticals Inc - Mcm Candidates Demonstrated Chemical and Biological (CB) Neutralizing Activity in Well-Validated in Vitro and Ex Vivo Models
Express News | TFF Pharmaceuticals Inc - Co and Leidos to Advance Next-Generation Biodefense Countermeasures Under Darpa PPB Program Into Preclinical Testing